Clinical Trials Logo

Clinical Trial Summary

Taybi-Linder syndrome (TALS, OMIM 210710) is a rare autosomal recessive disorder belonging to the group of microcephalic osteodysplastic primordial dwarfisms (MOPD). This syndrome is characterized by short stature, skeletal anomalies, severe microcephaly with brain malformations and facial dysmorphism, and is caused by mutations in RNU4ATAC. Although RNU4ATAC-associated TALS is a recognizable phenotype, an atypical presentation is sometimes observed, thus expanding the clinical spectrum (TALS-like phenotype).

This study aims to identify new variants involved in Taybi-Linder syndrome and associated phenotypes (i.e.TALS-like).

This non interventional study will be performed on patients with no proven mutation of RNU4ATAC and their blood relatives (19 samples total) by high throughput sequencing and genetic analysis of already collected deoxyribonucleic acid samples.

Altogether, such a study will allow a better understanding of the molecular mechanisms responsible for the Taybi-Linder syndrome and Taybi-Linder syndrome-like phenotypes as well as the pathophysiology of these devastating forms of microcephalic dwarfism.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03222947
Study type Observational
Source Hospices Civils de Lyon
Contact Audrey PUTOUX, MCU-PH
Phone 04 27 85 50 83
Email audrey.putoux@chu-lyon.fr
Status Not yet recruiting
Phase N/A
Start date September 2017
Completion date June 2018

See also
  Status Clinical Trial Phase
Recruiting NCT03902353 - Screening of Pulmonary Veino Occlusive Disease in Heterozygous EIF2AK4 Mutation Carriers N/A
Completed NCT02770807 - Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients Phase 3
Completed NCT02704260 - Genetic of SportS Induced Endofibrotic Remodeling N/A
Recruiting NCT06125093 - Study of an Early Parenting Intervention for Children With Genetic Abnormalities and Mental Health Problems N/A
Active, not recruiting NCT03211039 - Perinatal Precision Medicine N/A
Active, not recruiting NCT03918707 - Utility of Rapid Whole Genome Sequencing in the NICU: A Pilot Study
Completed NCT01255358 - Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients Phase 2
Recruiting NCT03458962 - Diagnostic Odyssey: Whole Genome Sequencing (WGS)
Completed NCT03420274 - Ensuring Patients' Informed Access to Noninvasive Prenatal Testing N/A
Terminated NCT03834987 - NGLY1 Deficiency: A Prospective Natural History Study
Enrolling by invitation NCT03385876 - Rapid Whole Genome Sequencing Study N/A
Recruiting NCT03967743 - Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders
Active, not recruiting NCT03642405 - Drug-induced Repolarization ECG Changes